In a letter to the FDA signed by 13 experts in the field of tobacco harm reduction, the authors urge that any advice on vaping and COVID-19 should be based on recognition of the pronounced difference in risk between smoking and vaping, the difficulty that many face in quitting nicotine use completely, the risks of harmful unintended consequences, and the strong association of smoking with poverty and various forms of disadvantage. In other words, they worry that the promotion of unfounded fears in relation to COVID-19 may drive vapers back to smoking, with destructive consequences for their health
At the CAGNY event, Howard Willard, chairman and CEO of Altria, announced a third market, Charlotte, N.C., in which it will conduct similar activities
The nicotine in e-cigarettes can still cause vasoconstriction (narrowing of blood vessels), potentially reducing blood flow to the scalp
The Buckeyes are here and the Buckeyes won